- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
The Biden administration could use the Defense Production Act to loosen up access to cell lines and manufacturing expertise for coronavirus vaccines if the World Trade Organization follows the U.S. government’s advice to waive patent protections for the vaccines, according to advocates for breaking coronavirus vaccine patents, including Knowledge Ecology International and Public Citizen.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us